Antares Pharma (ATRS) Posts Mixed Q2 Results

August 7, 2013 7:28 AM

Antares Pharma (NASDAQ: ATRS) reported Q2 EPS of ($0.04), $0.01 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found